Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemours (CC) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Chemours (CC) over the last 12 years, with Q3 2025 value amounting to $7.6 billion.

  • Chemours' Liabilities and Shareholders Equity rose 151.54% to $7.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $30.0 billion, marking a year-over-year decrease of 314.81%. This contributed to the annual value of $7.5 billion for FY2024, which is 896.64% down from last year.
  • Per Chemours' latest filing, its Liabilities and Shareholders Equity stood at $7.6 billion for Q3 2025, which was up 151.54% from $7.5 billion recorded in Q2 2025.
  • In the past 5 years, Chemours' Liabilities and Shareholders Equity ranged from a high of $8.3 billion in Q4 2023 and a low of $7.2 billion during Q1 2021
  • In the last 5 years, Chemours' Liabilities and Shareholders Equity had a median value of $7.6 billion in 2021 and averaged $7.6 billion.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first skyrocketed by 837.65% in 2021, then crashed by 896.64% in 2024.
  • Chemours' Liabilities and Shareholders Equity (Quarter) stood at $7.6 billion in 2021, then rose by 1.19% to $7.6 billion in 2022, then rose by 8.02% to $8.3 billion in 2023, then dropped by 8.97% to $7.5 billion in 2024, then increased by 0.76% to $7.6 billion in 2025.
  • Its Liabilities and Shareholders Equity stands at $7.6 billion for Q3 2025, versus $7.5 billion for Q2 2025 and $7.4 billion for Q1 2025.